Anzeige
Mehr »
Login
Donnerstag, 21.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Von Solarenergie zu digitalen Assets: Die Strategie hinter der 75-Prozent-Rallye
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 13.11.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
13.11.Abpro Announces Closing of Business Combination with Atlantic Coastal Acquisition Corp. II18Abpro Expected to Begin Trading on Nasdaq on Thursday, November 14, 2024, Under the Tickers "ABP" and "ABPWW" WOBURN, Mass. and NEW YORK, Nov. 13, 2024 /PRNewswire/...
► Artikel lesen
13.11.Africa Oil Corp.: Africa Oil Announces Third Quarter 2024 Results87VANCOUVER, BC, Nov. 13, 2024 /CNW/ - (TSX: AOI) (Nasdaq-Stockholm: AOI) - Africa Oil Corp. ("Africa Oil", "AOC" or the "Company") is pleased to announce its financial and operating...
► Artikel lesen
13.11.Instructure Holdings, Inc.: KKR and Dragoneer Complete Acquisition of Instructure114Investment to support newly private company's plans for product innovation and worldwide growth SALT LAKE CITY, Nov. 13, 2024 /PRNewswire/ -- Instructure Holdings...
► Artikel lesen
13.11.Blue Owl Technology Finance Corp. and Blue Owl Technology Finance Corp. II Announce Merger Agreement1Merger of two high-quality, diversified software-focused portfolios with substantial investment overlap significantly enhances scale Expected to create one of the...
► Artikel lesen
13.11.Strathcona Resources Ltd. Reports Third Quarter 2024 Financial and Operating Results, Provides 2025 Guidance and Announces Quarterly Dividend70CALGARY, AB, Nov. 13, 2024 /PRNewswire/ - Strathcona Resources Ltd. ("Strathcona" or the "Company") (TSX: SCR) today reported its third quarter 2024 financial...
► Artikel lesen
13.11.Exro Technologies Inc.: Exro Technologies Reports Third Quarter 2024 Financial Results413Delivered 74 e-propulsion systems to blue-chip OEM customers, a 106% increase over Q2 2024 and a new quarterly record. Record quarterly revenue of $11.0 million...
► Artikel lesen
13.11.New Pacific Metals Corp.: New Pacific Reports Financial Results For The Three Month Ended September 30, 202433VANCOUVER, BC, Nov. 13, 2024 /PRNewswire/ - New Pacific Metals Corp. ("New Pacific" or the "Company") reports its financial results for the three months ended...
► Artikel lesen
13.11.Electro-Sensors, Inc. Announces Third Quarter 2024 Financial Results32MINNETONKA, Minn., Nov. 13, 2024 /PRNewswire/ -- Electro-Sensors, Inc. (NASDAQ: ELSE), a leading global provider of machine monitoring sensors and hazard monitoring...
► Artikel lesen
13.11.Adecoagro S.A.: Adjusted EBITDA reached $341.0 million in 9M24. Second installment of the $35 million annual cash dividend to be paid in November. $96.3 million committed to shareholder distribution year-to-date.83LUXEMBOURG, Nov. 13, 2024 /PRNewswire/ -- Adecoagro S.A. (NYSE: AGRO, Bloomberg: AGRO US, Reuters: AGRO.K), a leading sustainable production company in South...
► Artikel lesen
13.11.Hillenbrand Reports Fiscal Fourth Quarter and Full Year 2024 Results72Q4 revenue of $838 million increased 10% compared to prior year; organic revenue decreased 1% Q4 GAAP EPS of $0.17 decreased from $0.24 in the prior year; adjusted...
► Artikel lesen
13.11.Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update21Achieves Key Milestone with Enrollment of First Two Patients in the Safety, Feasibility, and Dose Finding Study of Aethlon's Hemopurifier® in Patients with Solid...
► Artikel lesen
13.11.Drilling Tools International Corp. Reports 2024 Third Quarter Results53HOUSTON, Nov. 13, 2024 /PRNewswire/ -- Drilling Tools International Corp., (NASDAQ: DTI) ("DTI" or the "Company"), a global oilfield services company that designs...
► Artikel lesen
13.11.Kyverna Therapeutics Provides Business Update and Reports Third Quarter 2024 Financial Results60Multiple Key Leadership Appointments, Including Warner Biddle as CEO, Bringing Clinical, Commercial and Strategic Expertise in Cell Therapy Continuing to Advance...
► Artikel lesen
13.11.Intensity Therapeutics Inc.: Intensity Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update180First patient dosed in randomized, Phase 2 study in presurgical triple negative breast cancer SHELTON, Conn., Nov. 13, 2024 /PRNewswire/ -- Intensity Therapeutics...
► Artikel lesen
13.11.Cisco Systems, Inc.: Cisco Reports First Quarter Earnings7SAN JOSE, Calif., Nov. 13, 2024 /PRNewswire/ -- News Summary: Broad-based acceleration in product orders reflecting normalizing demand Product orders...
► Artikel lesen
13.11.Enliven Therapeutics, Inc.: Enliven Therapeutics Reports Third Quarter Financial Results and Provides a Business Update21Announced positive data from the Phase 1 clinical trial of ELVN-001 in CML, reporting a cumulative MMR rate of 44% (8/18) by 24 weeks and showing that ELVN-001 remains...
► Artikel lesen
13.11.Kulicke & Soffa Industries, Inc.: Kulicke & Soffa Reports Fourth Quarter 2024 Results62SINGAPORE, Nov. 13, 2024 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ: KLIC) ("Kulicke & Soffa," "K&S," "our," or the "Company"), today announced...
► Artikel lesen
13.11.Talphera, Inc.: Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update51Five sites actively screening with multiple patients having completed the study; two additional institutions expected to begin screening in the fourth quarter totaling...
► Artikel lesen
13.11.Anterix Inc. Reports Second Quarter Fiscal Year 2025 Results8WOODLAND PARK, N.J., Nov. 13, 2024 /PRNewswire/ -- Anterix (NASDAQ: ATEX) today announced its second quarter fiscal 2025 results and filed its Form 10-Q for the...
► Artikel lesen
13.11.Armata Pharmaceuticals, Inc.: Armata Pharmaceuticals Announces Third Quarter 2024 Results and Provides Corporate Update27LOS ANGELES, Nov. 13, 2024 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on...
► Artikel lesen
Seite:  Weiter >>